Rosen Law Firm is reminding investors who purchased FS KKR Capital Corp. (FSK) securities between May 8, 2024, and February 25, 2026, of an important July 6, 2026, lead plaintiff deadline. The lawsuit alleges that FS KKR Capital made false and/or misleading statements regarding its portfolio restructuring, valuation, and distribution strategy. Investors are encouraged to contact the Rosen Law Firm to join the class action.

Cboe Global Markets received SEC approval to offer extended trading hours for select multi-listed equity options, launching July 13. This initiative will introduce pre-market and post-market trading windows for roughly 20 highly liquid stocks, including Nvidia, Tesla, and Apple, aligning options trading with underlying securities. The move is part of Cboe's broader strategy to expand market access and meet global investor demand for trading outside standard hours.

Allison Ausband, Executive Vice President & Chief People Officer at Delta Air Lines Inc (DAL), sold 10,000 shares of the company on May 27, 2026. This transaction brings her total ownership to 128,854 shares. The stock is currently trading at $79.95, and GuruFocus assesses it as significantly overvalued with a price-to-GF-Value ratio of 1.48.

Charles Crisp, a Director at EOG Resources Inc (EOG), sold 1,887 shares of the company on May 28, 2026. This transaction increased his total holdings to 63,160.258 shares. The company's stock is currently considered fairly valued with a price-to-GF-Value ratio of 1.01.

Dermot Durcan, a Director at Cencora Inc (COR), purchased 4,000 shares of the company on May 28, 2026, increasing his total holdings to 27,767 shares. This transaction follows a pattern where Durcan has only bought shares in the past year, while the overall insider activity for Cencora shows more sells than buys. The stock is currently deemed fairly valued based on its price-to-GF-Value ratio of 0.92.

Kate Gebo, EVP of HR and Labor Relations at United Airlines, recently sold 40,000 shares of company stock worth approximately $4.22 million. The transactions occurred on May 26, 2026, with shares sold between $105.414 and $105.51. Following these sales and a gift of shares, Gebo directly holds 64,050 shares and indirectly holds another 64,050 shares.

Revvity Inc (RVTY) shares rose 4.6% to $101.22, though its GF Value of $120.39 suggests it is modestly undervalued with a 15.9% upside. The company has a GF Score of 75/100, indicating good overall quality, but a cautious outlook from insiders due to no recent trading activity. Its current P/E of 48.4x is higher than its historical median, but a forward P/E of 19.1x suggests potential for future earnings growth.

First Solar (FSLR) stock surged 10.8% on Thursday, reaching an 18-year intraday high of $310.42, marking its sixth consecutive daily gain. Analyst Catherine Gordon attributed this rise to falling yields, renewed policy momentum, and an anticipated Section 232 tariff announcement. The company's performance indicates strong investor confidence ahead of potential policy shifts.

Pfizer and Innovent Biologics have announced a global strategic collaboration to accelerate the research and development of 12 early-stage oncology medicines, including antibody-drug conjugates and multi-specific antibodies. The agreement involves licensing, co-development, and co-commercialization, combining Innovent’s discovery capabilities with Pfizer’s global R&D and commercial expertise. Innovent will receive an upfront payment of $650 million and is eligible for up to $9.85 billion in milestone payments, with profit-sharing for co-commercialized programs in the U.S. and Europe.

Citigroup has maintained its Neutral rating on Haemonetics (HAE) but raised the price target to $70 from $64, indicating cautious optimism for the company. Despite strong profitability and growth metrics, Haemonetics is considered undervalued by GuruFocus with a GF Value™ of $84.38 against its current trading price of $67.08. The company’s GF Score™ of 79/100, driven by solid financial strength, profitability, and growth, suggests a well-rounded performance, though momentum is currently low.